Clinical Trial Update: A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating ATG-022 in patients with advanced or metastatic solid tumors is currently recruiting. The trial is sponsored by Antengene Biologics L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ATG-022

Snippet

Sponsor: Antengene Biologics Limited | Conditions: Advanced/Metastatic Solid Tumors | Phase 1 | Status: RECRUITING